Oncogenic Ras and its role in tumor cell invasion and metastasis

被引：211

作者：

Campbell, PM ^{[1
]}

Der, CJ ^{[1
]}

机构：

[1] Univ N Carolina, Dept Pharmacol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

来源：

SEMINARS IN CANCER BIOLOGY | 2004年 / 14卷 / 02期

关键词：

Ras; oncogene; signaling; invasion; metastasis;

D O I：

10.1016/j.semcancer.2003.09.015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The processes by which cancer cells leave the tumor and enter adjacent tissue is known as invasion, whereas metastasis refers to secondary tumor colonization of tissue at a distance from the primary lesion. These two events are the most lethal of cancer phenomena and the signaling mechanisms that govern them are complex. The Ras signaling pathways are well represented in their involvement in tumor initiation, but considerably less is known about their contribution to invasion and metastasis. In this review, we discuss the current evidence for mutant Ras proteins as significant players in these aspects of cancer progression. (C) 2003 Elsevier Ltd. All rights reserved.

引用

页码：105 / 114

页数：10

共 132 条

[1] RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases
Aguirre-Ghiso, JA
Frankel, P
Farias, EF
Lu, ZM
Jiang, H
Olsen, A
Feig, LA
Joffe, EB
Foster, DA
[J]. ONCOGENE, 1999, 18 (33) : 4718 - 4725
[2] Ahn NG, 2001, METHOD ENZYMOL, V332, P417
[3] Al-Mulla F, 1998, J PATHOL, V185, P130, DOI 10.1002/(SICI)1096-9896(199806)185:2<130::AID-PATH85>3.0.CO
[4] 2-M
[5] Differences in in vitro invasive capacity induced by differences in Ki-Ras protein mutations
Al-Mulla, F
MacKenzie, EM
[J]. JOURNAL OF PATHOLOGY, 2001, 195 (05) : 549 - 556
[6] Kirsten ras mutations in patients with colorectal cancer:: the 'RASCAL II' study
Andreyev, HJN
Norman, AR
Cunningham, D
Oates, J
Dix, BR
Iacopetta, BJ
Young, J
Walsh, T
Ward, R
Hawkins, N
Beranek, M
Jandik, P
Benamouzig, R
Jullian, E
Laurent-Puig, P
Olschwang, S
Muller, O
Hoffmann, I
Rabes, HM
Zietz, C
Troungos, C
Valavanis, C
Yuen, ST
Ho, JWC
Croke, CT
O'Donoghue, DP
Giaretti, W
Rapallo, A
Russo, A
Bazan, V
Tanaka, M
Omura, K
Azuma, T
Ohkusa, T
Fujimori, T
Ono, Y
Pauly, M
Faber, C
Glaesener, R
de Goeij, AFPM
Arends, JW
Andersen, SN
Lövig, T
Breivik, J
Gaudernack, G
Clausen, OPF
De Angelis, P
Meling, GI
Rognum, TO
Smith, R
[J]. BRITISH JOURNAL OF CANCER, 2001, 85 (05) : 692 - 696
[7] Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study
Andreyev, HJN
Norman, AR
Cunningham, D
Oates, JR
Clarke, PA
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (09) : 675 - 684
[8] Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
Arbiser, JL
Moses, MA
Fernandez, CA
Ghiso, N
Cao, YH
Klauber, N
Frank, D
Brownlee, M
Flynn, E
Parangi, S
Byers, HR
Folkman, J
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (03) : 861 - 866
[9] Role of the IκB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells
Arsura, M
Mercurio, F
Oliver, AL
Thorgeirsson, SS
Sonenshein, GE
[J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (15) : 5381 - 5391
[10] Gelsolin is a downstream effector of rac for fibroblast motility
Azuma, T
Witke, W
Stossel, TT
Hartwig, JH
Kwiatkowski, DJ
[J]. EMBO JOURNAL, 1998, 17 (05) : 1362 - 1370

← 1 2 3 4 5 6 7 8 9 10 →